Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
| MSB | MSB Clinical Program Update For MPC-150-IM In Heart Failure | 18/04/18 | ||
| MSB | Mesoblast Phase 3 CLBP Trial Completes Enrollment | 29/03/18 | ||
| MSB | Change in substantial holding | 09/03/18 | ||
| MSB | MSB Enters Into $75 Million Non-Dilutive Credit Facility | PRICE SENSITIVE | 07/03/18 | |
| MSB | Mesoblast Provides Half Year Results and Corporate Update | 28/02/18 | ||
| MSB | Half Year Results Presentation | 28/02/18 | ||
| MSB | Half Year Report and Accounts (including Appendix 4D) | PRICE SENSITIVE | 28/02/18 | |
| MSB | GVHD Day 28 Results Presentation | PRICE SENSITIVE | 23/02/18 | |
| MSB | Appendix 4C - quarterly | PRICE SENSITIVE | 31/01/18 | |
| MSB | Change of Director's Interest Notices | 25/09/17 | ||
| MSB MSB Clinical Program Update For MPC-150-IM In Heart Failure | |||
| 18/04/18 | |||
| MSB Mesoblast Phase 3 CLBP Trial Completes Enrollment | |||
| 29/03/18 | |||
| MSB Change in substantial holding | |||
| 09/03/18 | |||
| MSB MSB Enters Into $75 Million Non-Dilutive Credit Facility | |||
| 07/03/18 | PRICE SENSITIVE | ||
| MSB Mesoblast Provides Half Year Results and Corporate Update | |||
| 28/02/18 | |||
| MSB Half Year Results Presentation | |||
| 28/02/18 | |||
| MSB Half Year Report and Accounts (including Appendix 4D) | |||
| 28/02/18 | PRICE SENSITIVE | ||
| MSB GVHD Day 28 Results Presentation | |||
| 23/02/18 | PRICE SENSITIVE | ||
| MSB Appendix 4C - quarterly | |||
| 31/01/18 | PRICE SENSITIVE | ||
| MSB Change of Director's Interest Notices | |||
| 25/09/17 | |||
